You are here: Industry Insights > small molecule

News List

Regen BioPharma sees success in Its pre-clinical small molecule optimization program for NR2F6 cphi-online
April 14, 2017
The company's small molecule drug program is aimed at treating cancer and autoimmune diseases.
RedHill Biopharma Announces Exclusive U.S. License from Entera Health for Commercial GI Product Ente b3cnewswire
April 06, 2017
RedHill Biopharma Ltd. announced the signing of an exclusive license agreement with Entera Health Inc. (“Entera Health”).
Metrion and Concept introduce integrated ion channel drug discovery service cphi-online
March 17, 2017
Supports small molecule ion channel drug discovery, from initial screening to development candidate.
A Review of Leukemia Targeting Drugs in 2016: Small Molecule Drugs and Monoclonal Antibody Drugs Par en-cphi
February 10, 2017
Leukemia is a clonal disease caused due to mutation of human hematopoietic stem cells, can cause symptoms like bleeding, anemia, organ infiltration and intestinal function failure of patients, and is a human disease of great harm.
Optibrium and eMolecules collaborate on chemistry data integration in StarDrop pharmaasia
February 08, 2017
Combining eMolecules’ collection of commercially available chemicals with StarDrop’s data analysis and compound design capabilities in drug discovery.
Enterome starts Phase I Crohn’s disease trial europeanpharmaceuticalreview
January 06, 2017
Enterome has launched a Phase I clinical study with its lead drug candidate EB8018, a small molecule designed to block FimH, as a potential new treatment for Crohn’s disease.

Previous page 1 2 Next page